TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Dow, S&P 500 and Nasdaq End at Record Highs on Trade-Deal Hopes, Merger Activity
MARKETS

Dow, S&P 500 and Nasdaq End at Record Highs on Trade-Deal Hopes, Merger Activity

  • By Rob Lenihan
  • Nov 25, 2019 4:16 PM EST
Jim Cramer: The One Thing That All These Mergers Have in Common
Video

Jim Cramer: The One Thing That All These Mergers Have in Common

  • Nov 25, 2019 12:12 PM EST
Novartis Reaches $9.7 Billion Deal to Buy Cholesterol Drugmaker Medicines Co.
STOCKS

Novartis Reaches $9.7 Billion Deal to Buy Cholesterol Drug Maker Medicines Co.

  • By Martin Baccardax
  • Nov 25, 2019 9:35 AM EST
Tiffany, Schwab, Novartis, 'Frozen 2,' Jerome Powell - 5 Things You Must Know
MARKETS

Tiffany, Schwab, Novartis, 'Frozen 2,' Jerome Powell - 5 Things You Must Know

  • By Joseph Woelfel
  • Nov 25, 2019 7:06 AM EST
Dow Futures Slide, Global Stocks Sputter as Trump Renews China Tariff Threat
STOCKS

Dow Futures Extend Gains, Global Stocks Bounce as Trade Optimism Lifts Sentiment

  • By Martin Baccardax
  • Nov 25, 2019 6:19 AM EST
Novartis to Swallow Up The Medicines Company for $9.7 Billion
STOCKS

Novartis to Swallow Up The Medicines Company for $9.7 Billion

  • By Adam Smith
  • Nov 24, 2019 5:10 PM EST
Novartis Reportedly Close to Buying Medicines Co.
MARKETS

Novartis Reportedly Close to Buying Medicines Co.

  • By Joseph Woelfel
  • Nov 24, 2019 8:13 AM EST
Shares of CRISPR Therapeutics Fall in After Hours Trading on Share Offering
STOCKS

Shares of CRISPR Therapeutics Fall in After Hours Trading on Share Offering

  • By Tom Bemis
  • Nov 19, 2019 8:37 PM EST
Nasdaq Closes at Record High, Stocks Mixed Over Home Depot, Trump Trade Threat
MARKETS

Nasdaq Closes at Record High, Stocks Mixed Over Home Depot, Trump Trade Threat

  • By Rob Lenihan
  • Nov 19, 2019 4:25 PM EST
Novartis to Swallow Up The Medicines Company for $9.7 Billion
STOCKS

Medicines Co. Surges After Cholesterol Drug Maker Linked to Novartis Takeover

  • By Martin Baccardax
  • Nov 19, 2019 9:38 AM EST
Home Depot, Kohl's, Boeing, Salesforce, Medicines Co. - 5 Things You Must Know
MARKETS

Home Depot, Kohl's, Boeing, Salesforce, Medicines Co. - 5 Things You Must Know

  • By Joseph Woelfel
  • Nov 19, 2019 7:20 AM EST
Medicines Co. Jumps on Pair of Bullish Notes
STOCKS

Medicines Co. Jumps on Pair of Bullish Notes

  • By Tony Owusu
  • Sep 25, 2019 11:28 AM EDT
Good Job Growth, Low Inflation: Cramer's 'Mad Money' Recap (Friday 6/1/18)
MARKETS

Medicines Co. Rises on Positive Phase 3 Trial for Cholesterol Lowering Therapy

  • By Brenda Bouw
  • Aug 26, 2019 1:42 PM EDT
Best and Worst Closed-End Funds
JIM CRAMER

Atlassian, AeroVironment, Granite Construction: 'Mad Money' Lightning Round

  • By Scott Rutt
  • Feb 7, 2018 6:27 AM EST
The Bottom? Not So Fast: Cramer's 'Mad Money' Recap (Tuesday 2/6/18)
JIM CRAMER

The Bottom? Not So Fast: Cramer's 'Mad Money' Recap (Tuesday 2/6/18)

  • By Scott Rutt
  • Feb 7, 2018 6:21 AM EST
Fight Off Complacency: Cramer's 'Mad Money' Recap (Fri 9/15/17)
JIM CRAMER

Fight Off Complacency: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Sep 16, 2017 6:44 AM EDT
Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Otonomy Shares Fall On Disappointing Phase 3 Data - Biotech Movers

  • By Armie Margaret Lee
  • Aug 30, 2017 9:46 AM EDT
Why Alexion's Gain In the C-Suite Doesn't Bode Well For Biogen Takeout Prospects
HEALTH

Biotech Movers: Novavax Falls Again After New Data on RSV Vaccine Fails to Excite

  • By Armie Margaret Lee
  • Jul 25, 2017 12:35 PM EDT
Rite Aid Stock Jumps Following Earnings Beat
STOCKS

How to Trade the Week's Most Active Stocks - Rite Aid, Amgen, MuleSoft and More

  • By Jonas Elmerraji
  • Mar 17, 2017 7:15 PM EDT
AveXis, Esperion and Amgen Among Biotech Movers
HEALTH

AveXis, Esperion and Amgen Among Biotech Movers

  • By Armie Margaret Lee
  • Mar 17, 2017 11:03 AM EDT
Regeneron stock
STOCKS

Biotech premarket movers: Ardelyx, Acorda Therapeutics, Medicines Co.

  • By Armie Margaret Lee
  • Feb 15, 2017 9:27 AM EST
Premarket Biotech Movers: Portola, Esperion, Medicines
STOCKS

Premarket biotech movers: Portola, Esperion, Medicines

  • By Armie Margaret Lee
  • Feb 3, 2017 9:32 AM EST
AveXis, Esperion and Amgen Among Biotech Movers
STOCKS

Amgen shares skyrocket on surprise patent victory

  • By Alicia McElhaney
  • Jan 6, 2017 10:13 AM EST
Medtronic Earnings Rebound in Third Quarter, Shares Climb
STOCKS

5 stocks insiders love right now

  • By Roberto Pedone
  • Dec 15, 2016 2:12 PM EST
Alder BioPharmaceuticals: Cramer's Top Takeaways
MARKETS

Why medicines co. (mdco) stock is falling today

  • By Annie Palmer
  • Oct 6, 2016 1:04 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.